Table 1. Association of DBH-AS1 expression with the clinicopathological features of the 156 patients with PC.
Features | n | lncRNA DBH-AS1 level | P value | |
---|---|---|---|---|
High | Low | |||
All cases | 156 | 78 | 78 | |
Age, years | 0.006 | |||
<60 | 88 | 29 | 59 | |
≥60 | 68 | 49 | 19 | |
Gender | <0.001 | |||
Male | 98 | 38 | 60 | |
Female | 58 | 40 | 18 | |
Tumor size (cm) | <0.001 | |||
<2 | 72 | 48 | 24 | |
≥2 | 84 | 30 | 54 | |
Lymph node metastasis | 0.419 | |||
Negative | 67 | 31 | 36 | |
Positive | 89 | 47 | 42 | |
TNM stage | 0.010 | |||
I and II | 84 | 50 | 34 | |
III and IV | 72 | 28 | 44 | |
Distant metastasis | 0.005 | |||
Negative | 97 | 57 | 40 | |
Positive | 59 | 21 | 38 | |
Perineural invasion | 0.170 | |||
Negative | 50 | 29 | 21 | |
Positive | 106 | 49 | 57 |
PC, pancreatic cancer; TNM, tumor, nodes, and metastases.